Page last updated: 2024-08-26

3,4-dihydroxybenzylamine and Skin Neoplasms

3,4-dihydroxybenzylamine has been researched along with Skin Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blarzino, C; Cini, C; Coccia, R; De Marco, F; Di Domenico, F; Foppoli, C; Morici, S; Paolini, F; Perluigi, M1
Wick, MM1

Other Studies

2 other study(ies) available for 3,4-dihydroxybenzylamine and Skin Neoplasms

ArticleYear
Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity.
    Journal of experimental & clinical cancer research : CR, 2009, Jan-08, Volume: 28

    Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Line, Tumor; Dopamine; Endosomes; Enzyme Activation; Gene Expression; Humans; Hydrogen-Ion Concentration; Melanins; Melanoma, Amelanotic; Monophenol Monooxygenase; Oncogene Proteins, Viral; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Transfection

2009
Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.
    The Journal of investigative dermatology, 1989, Volume: 92, Issue:5 Suppl

    Topics: Animals; DNA; Dopamine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanocytes; Melanoma; Mice; Skin Neoplasms

1989